PL3099714T3 - Linia komórkowa hybrydomy (my-c-cc0c2-259-1 a4) i jej zastosowanie do wytwarzania przeciwciała monoklonalnego przeciwko ludzkiemu swoistemu dla serca białku c wiążącemu miozynę (białko c, mybpc3, cmybp-c lub my-c) - Google Patents

Linia komórkowa hybrydomy (my-c-cc0c2-259-1 a4) i jej zastosowanie do wytwarzania przeciwciała monoklonalnego przeciwko ludzkiemu swoistemu dla serca białku c wiążącemu miozynę (białko c, mybpc3, cmybp-c lub my-c)

Info

Publication number
PL3099714T3
PL3099714T3 PL15713829T PL15713829T PL3099714T3 PL 3099714 T3 PL3099714 T3 PL 3099714T3 PL 15713829 T PL15713829 T PL 15713829T PL 15713829 T PL15713829 T PL 15713829T PL 3099714 T3 PL3099714 T3 PL 3099714T3
Authority
PL
Poland
Prior art keywords
protein
cc0c2
cmybp
mybpc3
producing
Prior art date
Application number
PL15713829T
Other languages
English (en)
Inventor
Ekkehard Weber
Rita Medek
Original Assignee
King's College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by King's College London filed Critical King's College London
Publication of PL3099714T3 publication Critical patent/PL3099714T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4712—Muscle proteins, e.g. myosin, actin, protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL15713829T 2014-01-27 2015-01-23 Linia komórkowa hybrydomy (my-c-cc0c2-259-1 a4) i jej zastosowanie do wytwarzania przeciwciała monoklonalnego przeciwko ludzkiemu swoistemu dla serca białku c wiążącemu miozynę (białko c, mybpc3, cmybp-c lub my-c) PL3099714T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102014000856.8A DE102014000856A1 (de) 2014-01-27 2014-01-27 Hybridom-Zelllinie (My-C-cC0C2-259-1A4) und deren Verwendung zur Herstellung eines monoklonalen Antikörpers gegen das humane, herzspezifische Myosin Binding Protein C (C-protein, MYBPC3, cMyBP-C oder My-C)
PCT/DE2015/000028 WO2015110114A2 (de) 2014-01-27 2015-01-23 Hybridom-zelllinie (my-c-cc0c2-259-1 a4) und deren verwendung zur herstellung eines monoklonalen antikörpers gegen das humane, herzspezifische myosin binding protein c (c-protein, mybpc3, cmybp-c oder my-c)
EP15713829.8A EP3099714B1 (de) 2014-01-27 2015-01-23 Hybridom-zelllinie (my-c-cc0c2-259-1 a4) und deren verwendung zur herstellung eines monoklonalen antikörpers gegen das humane, herzspezifische myosin binding protein c (c-protein, mybpc3, cmybp-c oder my-c)

Publications (1)

Publication Number Publication Date
PL3099714T3 true PL3099714T3 (pl) 2022-01-03

Family

ID=52807462

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15713829T PL3099714T3 (pl) 2014-01-27 2015-01-23 Linia komórkowa hybrydomy (my-c-cc0c2-259-1 a4) i jej zastosowanie do wytwarzania przeciwciała monoklonalnego przeciwko ludzkiemu swoistemu dla serca białku c wiążącemu miozynę (białko c, mybpc3, cmybp-c lub my-c)

Country Status (9)

Country Link
US (1) US10017745B2 (pl)
EP (1) EP3099714B1 (pl)
JP (1) JP6667443B2 (pl)
CN (1) CN106459927B (pl)
CA (1) CA2940505C (pl)
DE (2) DE102014000856A1 (pl)
ES (1) ES2879956T3 (pl)
PL (1) PL3099714T3 (pl)
WO (1) WO2015110114A2 (pl)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2829755B2 (ja) 1989-12-27 1998-12-02 株式会社第一ラジオアイソトープ研究所 抗ヒト心筋ｃプロテインモノクローナル抗体及び該抗体を産生するハイブリドーマ
WO2008104289A1 (en) * 2007-02-27 2008-09-04 Bayer Schering Pharma Aktiengesellschaft Mybpc3 as a biomarker for ppara modulators
WO2009104289A1 (ja) * 2008-02-19 2009-08-27 Yamauchi Emiko シネマライブ

Also Published As

Publication number Publication date
CN106459927B (zh) 2020-03-17
CA2940505A1 (en) 2015-07-30
DE112015000507A5 (de) 2017-03-30
US10017745B2 (en) 2018-07-10
ES2879956T3 (es) 2021-11-23
JP6667443B2 (ja) 2020-03-18
WO2015110114A2 (de) 2015-07-30
JP2017505618A (ja) 2017-02-23
CN106459927A (zh) 2017-02-22
US20170044501A1 (en) 2017-02-16
CA2940505C (en) 2022-08-02
EP3099714A2 (de) 2016-12-07
DE102014000856A1 (de) 2015-07-30
WO2015110114A3 (de) 2015-10-15
EP3099714B1 (de) 2021-04-28

Similar Documents

Publication Publication Date Title
IL274921A (en) BCMA-directed chimeric antigen receptor and uses thereof
HK1257518A1 (zh) 針對人白介素-2的免疫刺激性人源化單克隆抗體及其融合蛋白
ZA201700528B (en) Anti-ctla4 monoclonal antibody or antigen binding fragment thereof, medicinal composition and use
EP3505535A4 (en) MONOCLONAL ANTI-PD-1 ANTIBODY, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF
SG10201912494TA (en) Anti-cd3-binding domains and antibodies comprising them, and methods for their generation and use
ZA201608305B (en) Monoclonal antibodies against her2 epitope and methods of use thereof
EP3233916A4 (en) Humanized anti-acth antibodies and use thereof
EP3722313A4 (en) ANTIBODY OR ITS BINDING FRAGMENT TO THE ANTIGEN TO SPECIFICALLY RECOGNIZE A B-CELL MALIGNITY, CHEMERIC ANTIGEN RECEPTOR INCLUDING IT, AND ITS USE
EP3464355A4 (en) MONOCLONAL DSG2 ANTIBODIES AND USES THEREOF
IL280757A (en) Monoclonal antibodies against human TIM-3
EP3590964A4 (en) IMPROVED MONOCLONAL ANTI-VEGFR-2 ANTIBODY
EP3095796A4 (en) Anti-human probdnf monoclonal antibody, and uses thereof in pains
EP3177320A4 (en) Human monoclonal antibodies against epha4 and their use
IL267271A (en) Antibodies against il-5
SI3269735T1 (sl) Protitelo proti sklerostinu, antigen-vezavni fragment in medicinska uporaba le-tega
IL272733A (en) Monoclonal antibodies against pathological alpha-synuclein, and methods using same
EP3209686A4 (en) Monoclonal anti-gpc-1 antibodies and uses thereof
EP3524677A4 (en) ANTI-FZD10 MONOCLONAL ANTIBODIES, AND APPLICATION THEREOF
PL3099714T3 (pl) Linia komórkowa hybrydomy (my-c-cc0c2-259-1 a4) i jej zastosowanie do wytwarzania przeciwciała monoklonalnego przeciwko ludzkiemu swoistemu dla serca białku c wiążącemu miozynę (białko c, mybpc3, cmybp-c lub my-c)
DE112015000512A5 (de) Hybridom-Zelllinie (My-C-cC0C2-235-3H8) und deren Verwendung zur Herstellung eines monoklonalen Antikörpers gegen das humane, herzspezifische Myosin Bindung Protein C (C-protein), MYBPC3, cMyBP-C oder My-C)
EP3221350A4 (en) Mortalin peptides and antibodies and uses thereof for inhibiting mortalin activity and treating a disease associated with a pathological cell
ZA202001042B (en) Antibody specifically binding to pauf protein, and use thereof